Xylem Polarimeters Measure Chiral Compounds
The ADP600 Series high accuracy Peltier temperature-controlled polarimeters from Xylem?s Bellingham + Stanley brand measure chiral compounds and other optically active substances.
The ADP600 Series high accuracy Peltier temperature-controlled polarimeters from Xylem’s Bellingham + Stanley brand measure chiral compounds and other optically active substances. The polarimeters are available as single, dual, and multiple wavelength derivatives covering the visible spectrum and the ultraviolet region. ADP600 polarimeters have an extensive interfacing capability and may be configured to operate in secure environments in accordance with FDA regulation 21 CFR Part 11 and also meet the requirements of US, European, and Japanese pharmacopeia. A full-color, high-definition touchscreen graphical user interface simplifies operation. A full range of accessories is available including low-volume, standard, and flow-through sample tubes as well as United Kingdom Accreditation Service-certified, quartz control plates.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
